Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. It offers peritoneal dialysis and hemodialysis, renal replacement therapies and other organ support therapies, sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, drug reconstitution devices, and parenteral nutrition therapies.

Employee Rating

3.3More
TypePublic
HQDeerfield, US
Founded1931
Size (employees)47,000 (est)
Websitebaxter.com
Baxter International was founded in 1931 and is headquartered in Deerfield, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Baxter International

Jose Almeida

Jose Almeida

Chairman, President and Chief Executive Officer
John Forsyth

John Forsyth

Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
James Gavin

James Gavin

Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Munib Islam

Munib Islam

Partner and Head of Equities Research, Third Point LLC
Michael Mahoney

Michael Mahoney

Chairman, President and Chief Executive Officer, Boston Scientific Corporation
Cathy Smith

Cathy Smith

Executive Vice President and Chief Financial Officer, Target Corporation
Show more

Baxter International Office Locations

Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Show all (38)
Report incorrect company information

Baxter International Financials and Metrics

Baxter International Revenue

Embed Graph
Baxter International's revenue was reported to be $10.56 b in FY, 2017
USD

Revenue (Q2, 2018)

2.8b

Gross profit (Q2, 2018)

1.2b

Gross profit margin (Q2, 2018), %

43.6%

Net income (Q2, 2018)

343.0m

EBIT (Q2, 2018)

384.0m

Market capitalization (9-Nov-2018)

33.8b

Closing stock price (9-Nov-2018)

63.5

Cash (30-Jun-2018)

2.9b
Baxter International's current market capitalization is $33.8 b.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

10.0b10.2b10.6b

Revenue growth, %

(40%)2%

Cost of goods sold

5.8b6.1b6.1b

Gross profit

4.1b4.1b4.5b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

3.8b4.0b4.3b4.2b3.8b3.9b2.5b2.4b2.6b2.6b2.5b2.6b2.7b2.8b

Cost of goods sold

1.8b2.0b2.2b2.1b2.0b2.0b1.5b1.4b1.6b1.5b1.4b1.5b1.6b1.6b

Gross profit

1.9b2.0b2.0b2.1b1.8b1.9b1.0b965.0m972.0m1.1b1.0b1.1b1.1b1.2b

Gross profit Margin, %

52%50%48%49%48%49%42%41%38%42%42%43%42%44%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.7b2.9b2.2b2.8b3.4b

Inventories

3.5b3.6b1.6b1.4b1.5b

Current Assets

10.0b10.4b11.8b6.6b7.3b

PP&E

7.8b8.7b4.4b4.3b4.6b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

2.4b2.0b1.9b2.1b2.5b6.7b2.0b2.2b2.6b2.6b2.9b3.8b2.9b2.9b

Inventories

3.6b3.7b3.8b3.7b3.5b3.8b1.7b1.7b1.6b1.6b1.5b1.5b1.6b1.6b

Current Assets

9.6b9.4b9.5b9.6b9.7b14.5b11.1b8.0b6.8b6.6b6.6b7.7b7.0b6.9b

PP&E

7.5b8.0b8.2b8.4b8.5b9.0b4.3b4.4b4.3b4.3b4.3b4.3b4.6b4.5b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

2.0b2.5b968.0m5.0b717.0m

Depreciation and Amortization

761.0m

Inventories

(311.0m)(439.0m)1.6b80.0m76.0m

Accounts Payable

84.0m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Net Income

544.0m556.0m1.1b468.0m430.0m762.0m763.0m3.4b4.6b4.7b272.0m537.0m389.0m732.0m

Depreciation and Amortization

236.0m489.0m497.0m593.0m189.0m395.0m599.0m194.0m378.0m192.0m387.0m

Inventories

(233.0m)(360.0m)(439.0m)(205.0m)(26.0m)(25.0m)(11.0m)(29.0m)(38.0m)(56.0m)(134.0m)

Accounts Payable

(236.0m)(222.0m)(34.0m)14.0m(343.0m)(326.0m)(262.0m)(112.0m)(103.0m)(109.0m)
USDY, 2018

Financial Leverage

1.9 x
Show all financial metrics
Report incorrect company information

Baxter International Online and Social Media Presence

Embed Graph
Report incorrect company information

Baxter International News and Updates

Bio-Mems Devices 2018 Global Market Key Players – Abbott Laboratories, Boston Scientific, Perkin Elmer, Medtronic, Baxter International – Analysis and Forecast to 2023

WiseGuyRerports.com Presents “Global Bio-Mems Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” New Document to its Studies Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Future detailed in new report by Kidney Dialysis Equipment Market 2018: by Asahi Kasei Medical, Baxter International, Nikkiso Group.

Global Kidney Dialysis Equipment Market is expected to grow at a Compound Annual Growth Rate (CAGR) of +6.8%. The base year considered for the study is 2018 and the forecast period considered is 2018 To 2025. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard

DUBLIN, Aug 31, 2018 /PRNewswire/ -- The "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" report has been added to...

Tissue Sealants Global Market 2018: Key Players – 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., C. R. Bard, Inc.

Tissue Sealants -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday

Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday

Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Baxter International Company Life and Culture

Report incorrect company information

Baxter International Frequently Asked Questions

  • When was Baxter International founded?

    Baxter International was founded in 1931.

  • Who are Baxter International key executives?

    Baxter International's key executives are Jose Almeida, John Forsyth and James Gavin.

  • How many employees does Baxter International have?

    Baxter International has 47,000 employees.

  • What is Baxter International revenue?

    Latest Baxter International annual revenue is $10.6 b.

  • What is Baxter International revenue per employee?

    Latest Baxter International revenue per employee is $224.7 k.

  • Who are Baxter International competitors?

    Competitors of Baxter International include Fresenius Medical Care, Medtronic and Generex Biotechnology.

  • Where is Baxter International headquarters?

    Baxter International headquarters is located at One Baxter Parkway, Deerfield.

  • Where are Baxter International offices?

    Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations.

  • How many offices does Baxter International have?

    Baxter International has 38 offices.